TechFlow, Oct. 21 — NewLimit, a longevity research company co-founded by Coinbase CEO, has announced $45 million in new funding. The round includes new investors such as Lilly Ventures, Duke University, S32_VC, and AbstractVC, as well as existing investors including Kleiner Perkins, Dimension Capital, Human Capital, and BoostVC.
According to Jacob Kimmel, co-founder and president of the company, this funding follows significant technical breakthroughs achieved over the past five months. NewLimit's primary research focuses on restoring youthful liver function and has made substantial progress. The company plans to initiate clinical studies within the next few years.
Add to Favorites
Share to Social Media
